Skip to main content
. 2020 Feb 19;20:100282. doi: 10.1016/j.eclinm.2020.100282

Table 1.

Demographic characteristics and underlying comorbidities of A(H7N9) patients at hospital admission.a

Characteristics A(H7N9) (N = 61) Rehabilitation of Pulmonary function (N = 23) Rehabilitation of Chest CT scan (N = 8)
Demographic characteristic
Age, median years (range) 50 (4-80) 49 (4-78) 21·5 (4-49)
Age group (years)
 0-4 1 (1·6) 1 (4·3) 1 (12·5)
 5-14 4 (6·6) 1 (4·3) 2 (25·0)
 15-24 2 (3·3) 2 (8·7) 2 (25·0)
 25-49 20 (32·8) 8 (34·8) 3 (37·5)
 50-64 14 (23·0) 5 (21·7) 0 (0·0)
 ≥65 20 (32·8) 6 (26·1) 0 (0·0)
Male 42 (68·9) 15 (65·2) 7 (87·5)
Underlying comorbiditiesb
 Chronic pulmonary disease 2 (3·3) 0 (0·0) 0 (0·0)
 Cardiovascular disease 13 (21·3) 7 (30·4) 0 (0·0)
 Diabetes mellitus 5 (8·2) 2 (8·7) 1 (12·5)
 Anemia 1 (1·6) 0 (0·0) 0 (0·0)
 Chronic atrophic gastritis 1 (1·6) 0 (0·0) 0 (0·0)
 Chronic liver diseasec 1 (1·6) 1 (4·3) 1 (12·5)
 Schizophrenia 1 (1·6) 0 (0·0) 1 (12·5)
 Tuberculosis 1 (1·6) 0 (0·0) 0 (0·0)
 Othersd 3 (4·9) 1 (4·3) 0 (0·0)
 Any Underlying comorbidities 27 (44·3) 10 (43·5) 3 (37·5)
a

Figures are No. (%) unless stated otherwise. NA: Data unavailable. The column of “Rehabilitation of pulmonary function and chest CT scan” represent A(H7N9) patients recovered during follow-up visit.

b

Comorbidities not mutually exclusive; some patients had multiple chronic comorbid diseases.

c

Suspected hepatitis B.

d

Other underlying comorbidities including: hemangioma, uterine fibroid and cerebellar atrophy.

HHS Vulnerability Disclosure